J. Wouter Jukema mainly investigates Internal medicine, Genome-wide association study, Cardiology, Genetics and Coronary artery disease. His biological study spans a wide range of topics, including Endocrinology and Surgery. His Genome-wide association study research is multidisciplinary, relying on both Case-control study, Genetic association, Bioinformatics and Medical genetics.
His studies deal with areas such as Positive predicative value, Multislice, Radiology and Vascular disease as well as Coronary artery disease. His Radiology research incorporates themes from Circulatory system and Revascularization. J. Wouter Jukema combines subjects such as Stroke and Hazard ratio with his study of Myocardial infarction.
J. Wouter Jukema mainly focuses on Internal medicine, Cardiology, Coronary artery disease, Endocrinology and Genome-wide association study. J. Wouter Jukema regularly links together related areas like Surgery in his Internal medicine studies. As part of one scientific family, J. Wouter Jukema deals mainly with the area of Cardiology, narrowing it down to issues related to the Hazard ratio, and often Stroke and Proportional hazards model.
As a member of one scientific family, J. Wouter Jukema mostly works in the field of Coronary artery disease, focusing on Radiology and, on occasion, Coronary angiography and Circulatory system. His Endocrinology study combines topics from a wide range of disciplines, such as Apolipoprotein E and Risk factor. His Genome-wide association study research is multidisciplinary, incorporating perspectives in Genetic association, Bioinformatics and Medical genetics.
His primary areas of investigation include Internal medicine, Cardiology, Genome-wide association study, Genetics and Acute coronary syndrome. The study incorporates disciplines such as Alirocumab and Endocrinology in addition to Internal medicine. Cardiology connects with themes related to Odds ratio in his study.
The Genome-wide association study study combines topics in areas such as PR interval, Disease, Genetic association and Medical genetics. His Hazard ratio study incorporates themes from Body mass index, Prospective cohort study, Proportional hazards model and Pravastatin. The concepts of his Myocardial infarction study are interwoven with issues in Coronary artery disease, Residual risk and Stroke.
His primary scientific interests are in Internal medicine, Genome-wide association study, Genetics, Cardiology and Alirocumab. His study in Acute coronary syndrome, Myocardial infarction, Randomized controlled trial, Lipoprotein and Lipoprotein is done as part of Internal medicine. His study in Myocardial infarction is interdisciplinary in nature, drawing from both Stroke and LDL Cholesterol Lipoproteins.
J. Wouter Jukema interconnects Bioinformatics, Medical genetics, Disease, Genetic association and Minor allele frequency in the investigation of issues within Genome-wide association study. His research integrates issues of Cognition and Cardiac conduction in his study of Genetics. His work deals with themes such as Dialysis, Interquartile range and Hazard ratio, which intersect with Cardiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
James Shepherd;Gerard J Blauw;Michael B Murphy;Edward Lem Bollen.
The Lancet (2002)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh.
The Lancet (2010)
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Heribert Schunkert;Inke R. König;Sekar Kathiresan;Muredach P. Reilly.
Nature Genetics (2011)
Defining the role of common variation in the genomic and biological architecture of adult human height
Andrew R. Wood;Tonu Esko;Jian Yang;Sailaja Vedantam.
Nature Genetics (2014)
Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study.
W. Bob Meijboom;Matthijs F.L. Meijs;Joanne D. Schuijf;Maarten J. Cramer.
Journal of the American College of Cardiology (2008)
Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels The Regression Growth Evaluation Statin Study (REGRESS)
J. Wouter Jukema;Albert V.G. Bruschke;Ad J. van Boven;Johan H.C. Reiber.
Genetic studies of body mass index yield new insights for obesity biology
Adam E. Locke;Bratati Kahali;Sonja I. Berndt;Anne E. Justice.
Faculty of Health; Institute of Health and Biomedical Innovation (2015)
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture
Karol Estrada;Unnur Styrkarsdottir;Evangelos Evangelou;Yi-Hsiang Hsu.
Nature Genetics (2012)
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
Pierluigi Tricoci;Zhen Huang;Claes Held;David J. Moliterno.
The New England Journal of Medicine (2012)
Prognostic value of multislice computed tomography coronary angiography in patients with known or suspected coronary artery disease.
Gabija Pundziute;Joanne D. Schuijf;Joanne D. Schuijf;J. Wouter Jukema;J. Wouter Jukema;Eric Boersma.
Journal of the American College of Cardiology (2007)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: